References
  1. Orphanet. The portal for rare diseases and orphan drugs. Pallister-Hall syndrome. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=672
  2. Johnston JJ, Sapp JC, Turner JT et al. Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Hum Mutation 2010; 31:1142-1154.
  3. Biesecker LG. What you can learn from one gene: GLI3. J Med Genet 2006; 43:465-469.
  4. Johnston JJ, Olivos-Glander I, Killoran C et al. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Am J Hum Genet 2005; 76: 609-622.
  5. Hall JG, Pallister SK, Clarren SK et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly - a new syndrome? Part I. Clinical, causal, and pathogenetic considerations. Am J Med Genet 1980; 7:47-74.
  6.  Clarren SK, Alvord EC, Hall JG. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly-a new syndrome? Part II. Neuropathological considerations. Am J Med Genet 1980; 7: 75-83.
  7. A Mahtabfar, N Buckley, S Murphy, S Danish, I Marshall. Pallister-Hall Syndrome Presenting in Adolescence. Case Reports in Genetics 2019; 2019: 1 – 4.
  8. Biesecker LG. Pallister-Hall Syndrome. 2000 May 25 [Updated 2017 May 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1465/
  9. Démurger F, Ichkou A, Mougou-Zerelli S, et al. New insights into genotype-phenotype correlation for GLI3 mutations. Eur J Hum Genet 2015; 23(1): 92-102.
  10. J.G. Hall. The early history of Pallister–Hall syndrome—Buried treasure of a sort. Gene 2016; 589 (2):100-103.
  11. Boudreau EA, Liow K, Frattali CM, Wiggs E, Turner JT, Feuillan P, Sato S, Patsalides A, Patronas N, Biesecker LG, Theodore WH. Hypothalamic hamartomas and seizures: distinct natural history of isolated and Pallister-Hall syndrome cases. Epilepsia 2005; 46 (1):42-47.
  12. R Henith, R Ayan, D Harsh, P Rajan, S Jayaprakash, K Sadishkumar. Short stature and delayed puberty in a non-syndromic patient of hypothalamic hamartoma with panhypopituitarism. Indian Journal of Endocrinology and Metabolism 2018; 22 (Suppl 1): S17-S93.
  13. Courtney E, Swee D.S, Ishak D et al.  A delayed diagnosis of Pallister-Hall syndrome in an adult male following the incidental detection of a hypothalamic hamartoma. Hum Genome Var 2018 ; 5: 31.
  14. Ondrey F, Griffith A, Van Waes C, Rudy S, Peters K, Mc Cullagh L, Biesecker LG. Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. Am J Med Genet A. 2000; 94(1):64–67.
  15. Stevens CA, Ledbetter JC. Significance of bifid epiglottis. Am J Med Genet A. 2005; 134(4):447–449.
  16. C. Galasso,G. Scirè,F. Fabbri,G.L. Spadoni,C.E. Killoran,L.G. Biesecker,B. Boscherini. Long-term treatment with growth hormone improves final height in a patient with Pallister-Hall syndrome. Am J Med Genet 2001; 99(2):128-131.